Patents by Inventor Stanley LASCH

Stanley LASCH has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMBINATION THERAPY FOR THE TREATMENT OF AUTOIMMUNE DISEASES
    Publication number: 20220257755
    Abstract: The present invention pertains to compounds and their combination for use in the prevention or therapy of a subject suffering from an autoimmune disease such as diabetes type 1. Provided are antagonists of T-cells that are used in combination with antagonists of the cytokine CXCL10, sequentially or concomitantly, in a subject suffering from an autoimmune disease, in particular diabetes type 1.
    Type: Application
    Filed: December 27, 2021
    Publication date: August 18, 2022
    Inventors: URS CHRISTEN, STANLEY LASCH, MICHAEL PARNHAM
  • COMBINATION THERAPY FOR THE TREATMENT OF AUTOIMMUNE DISEASES
    Publication number: 20190351056
    Abstract: The present invention pertains to compounds and their combination for use in the prevention or therapy of a subject suffering from an autoimmune disease such as diabetes type 1. Provided are antagonists of T-cells that are used in combination with antagonists of the cytokine CXCL10, sequentially or concomitantly, in a subject suffering from an autoimmune disease, in particular diabetes type 1.
    Type: Application
    Filed: August 2, 2019
    Publication date: November 21, 2019
    Inventors: URS CHRISTEN, STANLEY LASCH, MICHAEL PARNHAM
  • Combination therapy for the treatment of autoimmune diseases
    Patent number: 10413605
    Abstract: The present invention pertains to compounds and their combination for use in the prevention or therapy of a subject suffering from an autoimmune disease such as diabetes type 1. Provided are antagonists of T-cells that are used in combination with antagonists of the cytokine CXCL10, sequentially or concomitantly, in a subject suffering from an autoimmune disease, in particular diabetes type 1.
    Type: Grant
    Filed: April 8, 2014
    Date of Patent: September 17, 2019
    Assignee: FRAUNHOFER-GESELLSCHAFT ZUR FÖRDERUNG DER ANGEWANDTEN FORSCHUNG E.V.
    Inventors: Urs Christen, Stanley Lasch, Michael Parnham
  • COMBINATION THERAPY FOR THE TREATMENT OF AUTOIMMUNE DISEASES
    Publication number: 20170021018
    Abstract: The present invention pertains to compounds and their combination for use in the prevention or therapy of a subject suffering from an autoimmune disease such as diabetes type 1. Provided are antagonists of T-cells that are used in combination with antagonists of the cytokine CXCL10, sequentially or concomitantly, in a subject suffering from an autoimmune disease, in particular diabetes type 1.
    Type: Application
    Filed: April 8, 2014
    Publication date: January 26, 2017
    Inventors: Urs CHRISTEN, Stanley LASCH, Michael PARNHAM